ELEKTA LAUNCHES NEW LINEAR ACCELERATOR AT 2007 ESTRO TO EXPAND CANCER TREATMENT AVAILABILITY

ELEKTA LAUNCHES NEW LINEAR ACCELERATOR AT 2007 ESTRO TO EXPAND CANCER TREATMENT
AVAILABILITY

PRESS RELEASE	
Stockholm, Sweden, September 10, 2007

Elekta today unveiled a new member of the Elekta family of linear accelerators
at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2007
meeting. At an unveiling ceremony in the Elekta booth, Elekta President & CEO
Tomas Puusepp announced the launch of Elekta Compact™, a new addition to
Elekta's product line of linear accelerators that offers an easy to implement,
more affordable solution for radiation therapy.

Elekta Compact was purposefully designed with a single low-energy photon beam
and a small footprint specifically, so it is ideally positioned for use in a
small treatment room and in specialized markets. Its efficient design makes it
more accessible to a wider range of health care providers who want to give their
patients the optimal care in radiation therapy. “Elekta is committed to fighting
cancer and enhancing patients' quality of life,” says Tomas Puusepp. “With the
addition of Elekta Compact to our product portfolio, Elekta can offer linear
accelerator systems across the full spectrum of price and performance
specifications. This is an important launch for Elekta, since Elekta Compact
opens up a new market for us. I believe that this system will significantly
contribute to our continued growth and further strengthen our position in
countries such as China and India”, ends Puusepp.

Smaller footprint targets untapped markets

In rooms that previously contained a Cobalt unit, or a treatment room with
limited space, Elekta Compact may be an appropriate first step. “For former
Cobalt users who want a simple linear accelerator as a ‘workhorse' in providing
cancer treatment with fewer complications, Elekta Compact can fill a treatment
room that might otherwise lay empty,” says Olof Sandén, Executive Vice President
Region  Europe at Elekta.

Elekta Compact was designed and positioned to give all customers access to this
exceptional product. “We haven't forgotten that there's a need for appropriate
products to meet all customers' needs,” says Russ Cox, Manager of Oncology
Product Management and Senior Product Manager of Precision Radiation Therapy
Systems at Elekta. “For countries needing to rapidly increase treatment capacity
and those countries where Cobalt replacements are becoming more common, this is
an ideal machine.”

Elekta Compact users will have access to electronic treatment records and
sophisticated information management systems to help streamline workflow.
“Elekta Compact begins as a simple point-and-shoot precision radiation treatment
system,” says Cox, “and we make available an interface to allow the output of
treatment parameters to external record-and-verify systems such as the MOSAIQ™
system provided by Elekta.”

Elekta Compact upgradeable to higher-end product

Elekta Compact has various upgrade paths to a higher-value product. “A mini
multi-leaf collimator from Elekta can be mounted along with associated small
field cones for stereotactic radiotherapy and radiosurgery,” explains Cox. In
addition, the user can start with an Elekta Precise standard tabletop and
upgrade to all forms of carbon fiber tabletops based on the customer's
individual clinical needs. 

In keeping with Elekta's ESTRO theme, “Moving forward together,” Elekta is
showcasing the entire Elekta family of products and services, including Elekta's
flagship products together with integrated product innovations from all Elekta
companies. 


******






For further information, please contact:

Peter Ejemyr, Group VP Corporate Communications, Elekta AB
Tel: +46 733 611 000 (mobile), e-mail: peter.ejemyr@elekta.com  

About Elekta

Elekta is an international medical-technology Group, providing meaningful
clinical solutions, comprehensive information systems and services for improved
cancer care and management of brain disorders. All of Elekta's solutions employ
non-invasive or minimally invasive techniques and are therefore clinically
effective, gentle on the patient and cost-effective. 

Clinical solutions include among others Leksell Gamma Knife® for non-invasive
treatment of brain disorders and Elekta Synergy® for image guided radiation
therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April
2005, the Elekta Group is the world's largest supplier of oncology software. 

Elekta's systems and solutions are used at over 4,000 hospitals around the world
to treat cancer and manage clinical operations as well as to diagnose and treat
brain disorders, including tumors, vascular malformations and functional
disorders. 

With approx. 2,000 employees, Elekta's corporate headquarter is located in
Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange
under the ticker EKTAb. For more information about Elekta, please visit
www.elekta.com.